MerciaPharma

Titan Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of treatments for central nervous system disorders, cardiovascular disease, bone disease and other disorders. Titan's products in development utilize technologies that have the potential to significantly improve the treatment of these diseases. Titan also establishes partnerships with government institutions and other leading pharmaceutical development companies. Titan Pharmaceuticals is headquartered in San Francisco.

Actinium Pharmaceuticals, Inc., based in New York, NY, is a biopharmaceutical company focused on developing targeted radiotherapies for patients with unmet medical needs. Their pipeline includes Antibody Radiation Conjugates for targeted conditioning and combination therapies, with a particular focus on CD33 targeting for AML treatment. With positive top-line results from their pivotal Phase 3 SIERRA Trial, Actinium is at the forefront of developing innovative therapies such as Iomab-B and Actimab-A to provide effective and personalized treatment options for patients. Their commitment to advancing targeted conditioning and radiotherapy technologies underscores their dedication to improving outcomes for individuals facing challenging medical conditions.Generated from the website

Mitsubishi Tanabe Pharma America (MTPA) is dedicated to assisting individuals facing serious and incapacitating illnesses. The company's mission is centered around providing support to those in need of treatment for challenging diseases. Generated from their website's infomation